MedTrace Logo

Remote Postpartum Blood Pressure Monitoring and Cardiovascular Education

NCT06920563 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 296

Last updated 2025-04-09

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if patient education and regular text reminders are a feasible intervention to engage patients and reduce post partum hypertension. The main questions it aims to answer are:

Is a structured postpartum remote blood pressure monitoring intervention with education and individualized medication initiation/adjustment follow-up by televisit feasible? Does a structured program reduce the occurrence of postpartum hypertension, ED visits, hospital readmissions, and adverse outcomes?

Participants will:

View an educational video on HDP post-delivery Receive 1-2 times daily text messages for 6 weeks postpartum Have their blood pressure medications adjusted to lower targets post partum

Conditions

  • Pre-Eclampsia; Complicating Pregnancy
  • Gestational Hypertension

Interventions

OTHER

Video

Those in the intervention arm will watch a short educational video.

OTHER

Text Reminder

Those in the intervention group will receive regular text message reminders to check their blood pressures

OTHER

Blood pressure threshold

Those in the intervention group will have a lower blood pressure threshold to titrate their BP medications towards

Sponsors & Collaborators

  • Ochsner Health System

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-17
Primary Completion
2026-10-16
Completion
2026-10-16

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06920563 on ClinicalTrials.gov